Article Text

Download PDFPDF
Venous cystic adventitial disease: to cure or manage? A case series
  1. David Flynn,
  2. Joshua Tesar,
  3. Samantha Peden,
  4. Simon Quinn,
  5. Allan Kruger and
  6. Jason Jenkins
  1. Department of Vascular Surgery, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia
  1. Correspondence to Dr David Flynn; deflynn75{at}gmail.com

Abstract

Venous cystic adventitial disease is a rare vascular condition that can have significant effects on a patient’s quality of life. The clinical presentation of venous cystic adventitial disease is variable, and there are no established guidelines on investigation or treatment of the disease. We present a series of three patients with venous cystic adventitial disease of the common femoral vein, treated within a single vascular surgery unit. Each of the three patients presented within 18 months of each other, despite the rarity of the disease. These are the only known cases treated within this vascular surgery unit. The investigation, management and treatment of each patient are individualised, with a management focus on quality of life.

  • vascular surgery
  • radiology

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Contributors DF was involved in the conceptualisation and design of the study, acquisition of data, drafting, revision and final approval. JT was involved in conceptualisation and design of the study as well as revision and final approval. SP was involved in the concept, design and review of the study. AK, SQ and JJ were involved in the design of the study, revisions and critical appraisal. All authors approved the final published version.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Case reports provide a valuable learning resource for the scientific community and can indicate areas of interest for future research. They should not be used in isolation to guide treatment choices or public health policy.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.